Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia

NCT00029380 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

NIH

Sponsor class

Conditions

Hematologic Diseases
Anemia, Sickle Cell
Beta-Thalassemia
Hematopoietic Stem Cell Transplantation

Interventions

DRUG: Sangstat
DRUG: Cyclophosphamide
DRUG: Busulfan
DRUG: Mycophenolate Mofetil
DRUG: Cyclosporine
PROCEDURE: Cord Blood Transplantation

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)